Evidence map›Paper›PMID 21945647›Full record

ArticleNeuroscience2011

A food restriction protocol that increases drug reward decreases tropomyosin receptor kinase B in the ventral tegmental area, with no effect on brain-derived neurotrophic factor or tropomyosin receptor kinase B protein levels in dopaminergic forebrain regions.

Y Pan, L Chau, S Liu, M V Avshalumov, M E Rice, K D Carr

Abstract read
In one paragraph

Article in Neuroscience, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
0.5field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. The mechanism of acute fasting-induced antidepressant-like effects in mice.Journal of cellular and molecular medicine · 2018
    Article
  10. Article
  11. Article
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Y PanDepartment of Psychiatry, New York University School of Medicine, 550 First Avenue, NY 10016, USA.
L Chau
S Liu
M V Avshalumov
M E Rice
K D Carr
New York University · US

Funding

CNS OPIOID MECHANISMS THAT MODULATE REWARD AND AVERSIONR01DA003956 · NIDA · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI CARR, KENNETH D · 1986 to 2018
$5.1M
Electrochemical Analysis of Dopamine ReleaseR01NS036362 · NINDS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI RICE, MARGARET E · 1997 to 2011
$3.3M
POSTDOCTORAL TRAINING IN RESEARCH ON ABUSED DRUGST32DA007254 · NIDA · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI CARR, KENNETH D · 1991 to 2013
$2.5M
Electrochemical Analysis of Dopamine ReleaseR56NS036362 · NINDS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI RICE, MARGARET E · 2007 to 2007
$423k
CNS Mechanisms that Modulate RewardR56DA003956 · NIDA · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI CARR, KENNETH D · 2008 to 2008
$321k
NIDA NIH HHS DA003956NIDA NIH HHS R01 DA003956NIDA NIH HHS R56 DA003956NIDA NIH HHS T32 DA007254NINDS NIH HHS NS036362NINDS NIH HHS R01 NS036362NINDS NIH HHS R56 NS036362
6 · The paper itself

Abstract

Food restriction (FR) decreases brain-derived neurotrophic factor (BDNF) expression in hypothalamic and hindbrain regions that regulate feeding and metabolic efficiency, while increasing expression in hippocampal and neocortical regions. Drugs of abuse alter BDNF expression within the mesocorticolimbic dopamine (DA) pathway, and modifications of BDNF expression within this pathway alter drug-directed behavior. Although FR produces a variety of striatal neuroadaptations and potentiates the rewarding effects of abused drugs, the effects of FR on BDNF expression and function within the DA pathway are unknown. The primary purpose of the present study was to examine the effect of FR on protein levels of BDNF and its tropomyosin receptor kinase B (TrkB) receptor in component structures of the mesocorticolimbic pathway. Three to four weeks of FR, with stabilization of rats at 80% of initial body weight, did not alter BDNF or TrkB levels in nucleus accumbens, caudate-putamen, or medial prefrontal cortex. However, FR decreased TrkB levels in the ventral tegmental area (VTA), without change in levels of BDNF protein or mRNA. The finding that FR also decreased TrkB levels in substantia nigra, with elevation of BDNF protein, suggests that decreased TrkB in VTA could be a residual effect of increased BDNF during an earlier phase of FR. Voltage-clamp recordings in VTA DA neurons indicated decreased glutamate receptor transmission. These data might predict lower average firing rates in FR relative to ad libitum fed subjects, which would be consistent with previous evidence of decreased striatal DA transmission and upregulation of postsynaptic DA receptor signaling. However, FR subjects also displayed elevated VTA levels of phospho-ERK1/2, which is an established mediator of synaptic plasticity. Because VTA neurons are heterogeneous with regard to neurochemistry, function, and target projections, the relationship(s) between the three changes observed in VTA, and their involvement in the augmented striatal and behavioral responsiveness of FR subjects to drugs of abuse, remains speculative.

Indexed as

RewardAnimalsBlotting, WesternBrain-Derived Neurotrophic FactorEnzyme-Linked Immunosorbent AssayFood DeprivationIllicit DrugsMaleMAP Kinase Signaling SystemPatch-Clamp TechniquesProsencephalonRatsRats, Sprague-DawleyReal-Time Polymerase Chain ReactionReceptor, trkBReverse Transcriptase Polymerase Chain ReactionBrain-Derived Neurotrophic FactorIllicit DrugsReceptor, trkBRNA, Messenger

Identifiers

PMID21945647
PMCPMC3210415
OpenAlexW2001652036

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.